Forbes - MUMBAI (Thomson Financial) - Standard & Poor's Ratings Services said it has placed the ratings of Vancouver-based Angiotech Pharmaceuticals Inc, including the 'B-' long-term corporate credit rating on negative watch after after the specialty ...